Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.74 USD | -0.59% | -2.72% | -14.15% |
May. 23 | CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer | MT |
May. 23 | CRISPR Therapeutics Announces Executive Changes | CI |
Financials (USD)
Sales 2024 * | 81.36M | Sales 2025 * | 332M | Capitalization | 4.56B |
---|---|---|---|---|---|
Net income 2024 * | -449M | Net income 2025 * | -392M | EV / Sales 2024 * | 32.9 x |
Net cash position 2024 * | 1.89B | Net cash position 2025 * | 1.64B | EV / Sales 2025 * | 8.81 x |
P/E ratio 2024 * |
-9.7
x | P/E ratio 2025 * |
-12
x | Employees | 407 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.94% |
Latest transcript on CRISPR Therapeutics AG
1 day | -0.59% | ||
1 week | -2.72% | ||
1 month | -0.13% | ||
3 months | -35.83% | ||
6 months | -21.72% | ||
Current year | -14.15% |
Managers | Title | Age | Since |
---|---|---|---|
Samarth Kulkarni
CEO | Chief Executive Officer | 45 | 15-07-31 |
Raju Prasad
DFI | Director of Finance/CFO | 40 | 23-03-13 |
Stephen Kennedy
CTO | Chief Tech/Sci/R&D Officer | 67 | 19-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Doug Treco Treco
BRD | Director/Board Member | 66 | 20-06-10 |
Simeon George
BRD | Director/Board Member | 47 | 15-04-28 |
Ali Behbahani
BRD | Director/Board Member | 48 | 15-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.82% | 254 M€ | +13.69% | - | |
8.55% | 2 M€ | -25.75% | ||
4.84% | 1 M€ | -.--% | - | |
4.53% | 0 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 53.74 | -0.59% | 1,119,168 |
24-05-30 | 54.06 | +0.39% | 761,338 |
24-05-29 | 53.85 | -1.81% | 1,121,012 |
24-05-28 | 54.84 | -0.72% | 852,502 |
24-05-24 | 55.24 | -0.88% | 623,806 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.15% | 4.56B | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- CRSP Stock